SAN DIEGO, Oct. 26 – Amersham Biosciences has agreed to distribute InforMax’s desktop software in Latin America, the companies announced Friday.
In the exclusive distribution agreement, Piscataway, NJ-based Amersham will distribute InforMax’s Vector NTI Suite molecular biology software in Brazil, Argentina, Bolivia, Guyana, Colombia, Peru, Surinam, French Guiana, Chile, Nicaragua, Venezuela, Ecuador, Uruguay, Paraguay, Mexico, Panama, El Salvador, Honduras, Guatemala, Costa Rica, and all Caribbean countries except Cuba.
Financial details of the agreement were not disclosed.
“Amersham Biosciences' leadership position in Latin America will be instrumental in expanding our customer base in those countries,” Alex Titomirov, CEO of Bethesda, Md.-based InforMax, said in a statement.
Last week, InforMax announced major changes in its leadership , including Titomirov, who is also chairman of InforMax’s board, stepping down from his CEO position upon the hiring of a replacement.
Amersham Biosciences, which last week was renamed from its former name Amersham Pharmacia Biotech , owns an equity stake in InforMax as part of a September 2000 collaboration deal integrating Amersham’s high throughput platforms with InforMax’s GenoMax software.